U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07165990) titled 'Produce Rx in High Risk Pregnant Mothers at Harris Health' on Sept. 02.
Brief Summary: The purpose of this study is to assess the effectiveness of a "Food is Medicine" (FIM) intervention on incidence of gestational diabetes mellitus (GDM) among pregnant women at risk for GDM within the Harris Health system.
Study Start Date: Sept. 08
Study Type: INTERVENTIONAL
Condition:
Gestational Diabetes Mellitus
Intervention:
BEHAVIORAL: Food is Medicine (FIM) Intervention
Intensive intervention phase - this phase starts at enrollment (<=14 weeks) through 28 weeks of gestation (or at the time of GDM diagnostic test) and women i) receive...